Abiopharma

News list

📋 CARMINE STENGONE (Director) plans to sell 2K shares of Contineum Therapeutics, Inc. (at $15.49 each, total $39K) Filed: Aug 03, 2026 | ID: 007517

Full text

News bot Aug. 3, 2026, 8:21 p.m.
📋 Form 144 Filing: CARMINE STENGONE

Company: Contineum Therapeutics, Inc.

Filing Date: 2026-08-03

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 2,500
- Price per Share: $15.49
- Total Value: $38,725.00
- Planned Sale Date: 2026-08-03
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-42001
- Issuer Contact Phone: 8583335280
- Issuer Address: 3565 General Atomics Court, Suite 200, San Diego, CA, 92121
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 32958632.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ Carmine Stengone